InfuSystem Holdings (INFU) Cash from Operations (2010 - 2026)
InfuSystem Holdings (INFU) posted Cash from Operations of 970000.0 for Q1 2026, down 86.39% on a QoQ basis from 7126000.0 in Q4 2025, and down 45.51% year-over-year from 1780000.0 in Q1 2025.
InfuSystem Holdings (INFU) Cash from Operations (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Cash from Operations history runs 17 years deep, the most recent figure standing at 970000.0 for Q1 2026.
- Quarterly Cash from Operations fell 45.51% year-over-year to 970000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 23598000.0 (up 7.94% YoY) and the FY2025 annual result came in at 24408000.0, up 19.3% from the prior year.
- Cash from Operations was 970000.0 for Q1 2026 at InfuSystem Holdings, down from 7126000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 9842000.0 in Q3 2024 and bottomed at 151000.0 in Q1 2023.
- A 5-year average of 4386882.35 and a median of 4264000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations tumbled 103.7% — and 2025, when it soared 372.15%.
- InfuSystem Holdings' Cash from Operations stood at 4566000.0 in 2022, then grew by 2.01% to 4658000.0 in 2023, then jumped by 70.27% to 7931000.0 in 2024, then declined by 10.15% to 7126000.0 in 2025, then sank by 86.39% to 970000.0 in 2026.
- Business Quant data shows INFU's Cash from Operations at 970000.0 in Q1 2026, 7126000.0 in Q4 2025, and 8493000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 970,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 970,000.00 |
| Mar 31, 2026 | 970,000.00 |
| Dec 31, 2025 | 7.13 Mn |
| Dec 31, 2025 | 7.13 Mn |
| Sep 30, 2025 | 8.49 Mn |
| Sep 30, 2025 | 8.49 Mn |
| Jun 30, 2025 | 7.01 Mn |
| Jun 30, 2025 | 7.01 Mn |
| Mar 31, 2025 | 1.78 Mn |
| Mar 31, 2025 | 1.78 Mn |
| Dec 31, 2024 | 7.93 Mn |
| Dec 31, 2024 | 7.93 Mn |
| Sep 30, 2024 | 9.84 Mn |
| Sep 30, 2024 | 9.84 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 377,000.00 |
| Mar 31, 2024 | 377,000.00 |
| Dec 31, 2023 | 4.66 Mn |
| Dec 31, 2023 | 4.66 Mn |